Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home
Company Information for

GRANULAR THERAPEUTICS LIMITED

C/O KRESTON REEVES LLP INNOVATION HOUSE, RAMSGATE ROAD, SANDWICH, KENT, CT13 9FF,
Company Registration Number
10650696
Private Limited Company
Active

Company Overview

About Granular Therapeutics Ltd
GRANULAR THERAPEUTICS LIMITED was founded on 2017-03-03 and has its registered office in Sandwich. The organisation's status is listed as "Active". Granular Therapeutics Limited is a Private Limited Company registered in UNITED KINGDOM with Companies House and the accounts submission requirement is categorised as SMALL
Key Data
Company Name
GRANULAR THERAPEUTICS LIMITED
 
Legal Registered Office
C/O KRESTON REEVES LLP INNOVATION HOUSE
RAMSGATE ROAD
SANDWICH
KENT
CT13 9FF
 
Previous Names
ULTRAHUMAN FIVE LIMITED04/02/2021
Filing Information
Company Number 10650696
Company ID Number 10650696
Date formed 2017-03-03
Country UNITED KINGDOM
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Active
Lastest accounts 31/12/2022
Account next due 30/09/2024
Latest return 
Return next due 31/03/2018
Type of accounts SMALL
Last Datalog update: 2024-03-06 23:47:32
Primary Source:Companies House
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of GRANULAR THERAPEUTICS LIMITED

Current Directors
Officer Role Date Appointed
JAMES EDWARD COLEMAN
Director 2017-03-03
JON EDWARDS
Director 2017-04-06
WILLIAM JAMES JONATHAN FINLAY
Director 2017-03-03
KEVIN STUART JOHNSON
Director 2017-04-06
Previous Officers
Officer Role Date Appointed Date Resigned
THE CAMBRIDGE PARTNERSHIP LIMITED
Company Secretary 2017-03-03 2017-07-28

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
JAMES EDWARD COLEMAN CREATIVE INDUSTRIES FEDERATION Director 2017-12-14 CURRENT 2013-11-27 Active
JAMES EDWARD COLEMAN ULTRAHUMAN THIRTEEN LIMITED Director 2017-03-03 CURRENT 2017-03-03 Liquidation
JAMES EDWARD COLEMAN LOCKBODY THERAPEUTICS LTD Director 2017-03-03 CURRENT 2017-03-03 Active
JAMES EDWARD COLEMAN ULTRAHUMAN TWELVE LIMITED Director 2017-03-03 CURRENT 2017-03-03 Liquidation
JAMES EDWARD COLEMAN ULTRAHUMAN SEVEN LIMITED Director 2017-03-03 CURRENT 2017-03-03 Liquidation
JAMES EDWARD COLEMAN ULTRAHUMAN TEN LIMITED Director 2017-03-03 CURRENT 2017-03-03 Liquidation
JAMES EDWARD COLEMAN ULTRAHUMAN ELEVEN LIMITED Director 2017-03-03 CURRENT 2017-03-03 Liquidation
JAMES EDWARD COLEMAN ULTRAHUMAN FOURTEEN LIMITED Director 2017-03-03 CURRENT 2017-03-03 Liquidation
JAMES EDWARD COLEMAN ULTRAHUMAN THREE LIMITED Director 2017-03-03 CURRENT 2017-03-03 Liquidation
JAMES EDWARD COLEMAN ULTRAHUMAN FOUR LIMITED Director 2017-03-03 CURRENT 2017-03-03 Active - Proposal to Strike off
JAMES EDWARD COLEMAN ULTRAHUMAN NINE LIMITED Director 2017-03-03 CURRENT 2017-03-03 Liquidation
JAMES EDWARD COLEMAN ULTRAHUMAN EIGHT LIMITED Director 2017-03-03 CURRENT 2017-03-03 Active
JAMES EDWARD COLEMAN ULTRAHUMAN TWO LIMITED Director 2017-03-01 CURRENT 2017-03-01 Active - Proposal to Strike off
JAMES EDWARD COLEMAN ULTRAHUMAN ONE LIMITED Director 2017-02-28 CURRENT 2017-02-28 Liquidation
JAMES EDWARD COLEMAN ULTRAHUMAN LIMITED Director 2015-12-16 CURRENT 2015-11-24 Liquidation
WILLIAM JAMES JONATHAN FINLAY ULTRAHUMAN THIRTEEN LIMITED Director 2017-03-03 CURRENT 2017-03-03 Liquidation
WILLIAM JAMES JONATHAN FINLAY LOCKBODY THERAPEUTICS LTD Director 2017-03-03 CURRENT 2017-03-03 Active
WILLIAM JAMES JONATHAN FINLAY ULTRAHUMAN TWELVE LIMITED Director 2017-03-03 CURRENT 2017-03-03 Liquidation
WILLIAM JAMES JONATHAN FINLAY ULTRAHUMAN SEVEN LIMITED Director 2017-03-03 CURRENT 2017-03-03 Liquidation
WILLIAM JAMES JONATHAN FINLAY ULTRAHUMAN TEN LIMITED Director 2017-03-03 CURRENT 2017-03-03 Liquidation
WILLIAM JAMES JONATHAN FINLAY ULTRAHUMAN ELEVEN LIMITED Director 2017-03-03 CURRENT 2017-03-03 Liquidation
WILLIAM JAMES JONATHAN FINLAY ULTRAHUMAN FOURTEEN LIMITED Director 2017-03-03 CURRENT 2017-03-03 Liquidation
WILLIAM JAMES JONATHAN FINLAY ULTRAHUMAN THREE LIMITED Director 2017-03-03 CURRENT 2017-03-03 Liquidation
WILLIAM JAMES JONATHAN FINLAY ULTRAHUMAN FOUR LIMITED Director 2017-03-03 CURRENT 2017-03-03 Active - Proposal to Strike off
WILLIAM JAMES JONATHAN FINLAY ULTRAHUMAN NINE LIMITED Director 2017-03-03 CURRENT 2017-03-03 Liquidation
WILLIAM JAMES JONATHAN FINLAY ULTRAHUMAN EIGHT LIMITED Director 2017-03-03 CURRENT 2017-03-03 Active
WILLIAM JAMES JONATHAN FINLAY ULTRAHUMAN TWO LIMITED Director 2017-03-01 CURRENT 2017-03-01 Active - Proposal to Strike off
WILLIAM JAMES JONATHAN FINLAY ULTRAHUMAN ONE LIMITED Director 2017-02-28 CURRENT 2017-02-28 Liquidation
WILLIAM JAMES JONATHAN FINLAY ULTRAHUMAN LIMITED Director 2016-02-18 CURRENT 2015-11-24 Liquidation
KEVIN STUART JOHNSON METHUSELAH HEALTH UK LIMITED Director 2018-04-06 CURRENT 2014-09-09 Active
KEVIN STUART JOHNSON ULTRAHUMAN ONE LIMITED Director 2017-04-06 CURRENT 2017-02-28 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN THIRTEEN LIMITED Director 2017-04-06 CURRENT 2017-03-03 Liquidation
KEVIN STUART JOHNSON LOCKBODY THERAPEUTICS LTD Director 2017-04-06 CURRENT 2017-03-03 Active
KEVIN STUART JOHNSON ULTRAHUMAN TWELVE LIMITED Director 2017-04-06 CURRENT 2017-03-03 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN SEVEN LIMITED Director 2017-04-06 CURRENT 2017-03-03 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN TEN LIMITED Director 2017-04-06 CURRENT 2017-03-03 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN ELEVEN LIMITED Director 2017-04-06 CURRENT 2017-03-03 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN FOURTEEN LIMITED Director 2017-04-06 CURRENT 2017-03-03 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN TWO LIMITED Director 2017-04-06 CURRENT 2017-03-01 Active - Proposal to Strike off
KEVIN STUART JOHNSON ULTRAHUMAN THREE LIMITED Director 2017-04-06 CURRENT 2017-03-03 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN FOUR LIMITED Director 2017-04-06 CURRENT 2017-03-03 Active - Proposal to Strike off
KEVIN STUART JOHNSON ULTRAHUMAN NINE LIMITED Director 2017-04-06 CURRENT 2017-03-03 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN EIGHT LIMITED Director 2017-04-06 CURRENT 2017-03-03 Active
KEVIN STUART JOHNSON REBALANCE (CAMBRIDGE) LIMITED Director 2016-12-06 CURRENT 2016-12-06 Liquidation
KEVIN STUART JOHNSON SUPERX LIMITED Director 2016-01-07 CURRENT 2015-11-10 Liquidation
KEVIN STUART JOHNSON ULTRAHUMAN LIMITED Director 2015-12-16 CURRENT 2015-11-24 Liquidation
KEVIN STUART JOHNSON CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED Director 2015-10-30 CURRENT 2015-07-15 Active
KEVIN STUART JOHNSON CRESCENDO BIOLOGICS LIMITED Director 2015-07-07 CURRENT 2007-11-13 Active
KEVIN STUART JOHNSON CAPELLA BIOSCIENCE LTD Director 2014-12-19 CURRENT 2014-11-07 Active
KEVIN STUART JOHNSON APCINTEX LIMITED Director 2014-06-16 CURRENT 2014-06-16 Active
KEVIN STUART JOHNSON LETSBEATSEPSIS Director 2014-05-19 CURRENT 2014-05-19 Active - Proposal to Strike off
KEVIN STUART JOHNSON INHIBITAXIN LIMITED Director 2013-06-25 CURRENT 2013-06-25 Liquidation
KEVIN STUART JOHNSON B3NGF LTD Director 2013-02-14 CURRENT 2013-02-14 Dissolved 2015-12-21
KEVIN STUART JOHNSON LEVICEPT LTD Director 2012-08-23 CURRENT 2012-08-23 Active

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2024-02-13CONFIRMATION STATEMENT MADE ON 21/01/24, WITH UPDATES
2023-10-09SMALL COMPANY ACCOUNTS MADE UP TO 31/12/22
2023-07-0407/06/23 STATEMENT OF CAPITAL GBP 67.91113
2023-07-0407/06/23 STATEMENT OF CAPITAL GBP 89.39765
2023-07-0426/06/23 STATEMENT OF CAPITAL GBP 94.31124
2023-03-14DIRECTOR APPOINTED DR THIBAUD PORTAL
2023-01-23CONFIRMATION STATEMENT MADE ON 21/01/23, WITH NO UPDATES
2022-08-19AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/21
2022-04-27CH01Director's details changed for Mr Francesco De Rubertis on 2022-04-27
2022-02-11APPOINTMENT TERMINATED, DIRECTOR KEVIN STUART JOHNSON
2022-02-11TM01APPOINTMENT TERMINATED, DIRECTOR KEVIN STUART JOHNSON
2022-01-26CONFIRMATION STATEMENT MADE ON 21/01/22, WITH UPDATES
2022-01-26CS01CONFIRMATION STATEMENT MADE ON 21/01/22, WITH UPDATES
2021-09-30AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/20
2021-05-19SH0112/04/21 STATEMENT OF CAPITAL GBP 67.91113
2021-05-19RES01ADOPT ARTICLES 19/05/21
2021-05-19MEM/ARTSARTICLES OF ASSOCIATION
2021-02-04RES15CHANGE OF COMPANY NAME 04/02/21
2021-01-21CS01CONFIRMATION STATEMENT MADE ON 21/01/21, WITH UPDATES
2020-11-26TM01APPOINTMENT TERMINATED, DIRECTOR JON EDWARDS
2020-11-26AP01DIRECTOR APPOINTED MR FRANCESCO DE RUBERTIS
2020-11-13CS01CONFIRMATION STATEMENT MADE ON 03/11/20, WITH UPDATES
2020-10-28RES01ADOPT ARTICLES 28/10/20
2020-10-20SH0106/10/20 STATEMENT OF CAPITAL GBP 66.21335
2020-10-20MEM/ARTSARTICLES OF ASSOCIATION
2020-09-24AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/19
2020-03-10CS01CONFIRMATION STATEMENT MADE ON 02/03/20, WITH NO UPDATES
2019-09-11AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/18
2019-03-11CS01CONFIRMATION STATEMENT MADE ON 02/03/19, WITH NO UPDATES
2018-06-01AASMALL COMPANY ACCOUNTS MADE UP TO 31/12/17
2018-05-01PSC08Notification of a person with significant control statement
2018-03-02CS01CONFIRMATION STATEMENT MADE ON 02/03/18, WITH UPDATES
2017-11-30AA01Current accounting period shortened from 31/03/18 TO 31/12/17
2017-11-21TM02Termination of appointment of the Cambridge Partnership Limited on 2017-07-28
2017-08-30AD01REGISTERED OFFICE CHANGED ON 30/08/17 FROM C/O Medicxi 25 Great Pulteney Street Soho London W1F 9LT England
2017-07-27PSC07CESSATION OF WILLIAM JAMES JONATHAN FINLAY AS A PSC
2017-07-27PSC07CESSATION OF JAMES EDWARD COLEMAN AS A PSC
2017-05-15AP01DIRECTOR APPOINTED DR KEVIN STUART JOHNSON
2017-05-15LATEST SOC15/05/17 STATEMENT OF CAPITAL;GBP 10
2017-05-15SH0106/04/17 STATEMENT OF CAPITAL GBP 10.00
2017-05-11RES01ADOPT ARTICLES 11/05/17
2017-05-08AP01DIRECTOR APPOINTED JON EDWARDS
2017-03-03MODEL ARTICLESMODEL ARTICLES ADOPTED: PRIVATE LIMITED BY SHARES (AMENDED PROVISIONS)
2017-03-03NEWINCCERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72110 - Research and experimental development on biotechnology




Licences & Regulatory approval
We could not find any licences issued to GRANULAR THERAPEUTICS LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
No legal notices or events such as winding-up orders or proposals to strike-off have been issued
Fines / Sanctions
No fines or sanctions have been issued against GRANULAR THERAPEUTICS LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 0
Mortgages/Charges outstanding 0
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 0
Details of Mortgagee Charges
GRANULAR THERAPEUTICS LIMITED does not have any mortgage charges so there is no mortgagee data available

  Average Max

This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology

Filed Financial Reports
Annual Accounts
2017-12-31
Annual Accounts
2018-12-31
Annual Accounts
2019-12-31
Annual Accounts
2020-12-31

These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on GRANULAR THERAPEUTICS LIMITED

Intangible Assets
Patents
We have not found any records of GRANULAR THERAPEUTICS LIMITED registering or being granted any patents
Domain Names
We do not have the domain name information for GRANULAR THERAPEUTICS LIMITED
Trademarks
We have not found any records of GRANULAR THERAPEUTICS LIMITED registering or being granted any trademarks
Income
Government Income
We have not found government income sources for GRANULAR THERAPEUTICS LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as GRANULAR THERAPEUTICS LIMITED are:

Outgoings
Business Rates/Property Tax
No properties were found where GRANULAR THERAPEUTICS LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded GRANULAR THERAPEUTICS LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded GRANULAR THERAPEUTICS LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.